Clinical and pharmacological group: & nbsp

Quinolones / fluoroquinolones

Included in the formulation
  • Aschlev
    solution d / infusion 
    MANAS MED, LTD     Russia
  • Glevo
    pills inwards 
  • Ivacin
    solution d / infusion 
  • L-OPTIC ROMFARM
    drops d / eye 
  • Lebel®
    pills inwards 
  • Levoximed
    solution d / infusion 
  • Levoleth® Р
    solution d / infusion 
  • Levoleth® Р
    pills inwards 
  • Levostar
    pills inwards 
    AKTAVIS GROUP, AO     Iceland
  • Levotek
    pills inwards 
  • Levotek
    solution d / infusion 
  • Levoflox
    pills inwards 
    Rowecq Limited     United Kingdom
  • Levoflox-Routek
    solution d / infusion 
    Rowecq Limited     United Kingdom
  • Levofloxabol®
    solution d / infusion 
    PREBAND PFC, LLC     Russia
  • Levofloxacin
    pills inwards 
    DALHIMFARM, OJSC     Russia
  • Levofloxacin
    solution d / infusion 
    OMELA, LTD.     Russia
  • Levofloxacin
    drops d / eye 
    BELMEDPREPARATY, RUP     Republic of Belarus
  • Levofloxacin
    pills inwards 
    RAFARMA, CJSC     Russia
  • Levofloxacin
    pills inwards 
  • Levofloxacin
    pills inwards 
    ATOLL, LLC     Russia
  • Levofloxacin
    solution d / infusion 
    KRASFARMA, JSC     Russia
  • Levofloxacin
    solution d / infusion 
    DALHIMFARM, OJSC     Russia
  • Levofloxacin
    pills inwards 
    VERTEKS, AO     Russia
  • Levofloxacin
    drops d / eye 
  • Levofloxacin
    solution d / infusion 
  • Levofloxacin
    solution d / infusion 
    BIOSINTEZ, PAO     Russia
  • Levofloxacin STADA
    pills inwards 
    NIZHFARM, JSC     Russia
  • Levofloxacin-LEXM
    pills inwards 
    PROTEK-SVM, LLC     Russia
  • Levofloxacin-Nova
    solution d / infusion 
    JODAS EKSPOIM, LLC     Russia
  • Levofloxacin-SOLOfarm
    drops d / eye 
    GROTEKS, LLC     Russia
  • Levofloxacin-Teva
    pills inwards 
  • Levofloxacin-Teva
    solution d / infusion 
  • Leobeg
    solution d / infusion 
  • Leflobact
    solution d / infusion 
    SYNTHESIS, OJSC     Russia
  • Leflobact
    pills inwards 
    SYNTHESIS, OJSC     Russia
  • Lefokcin
    pills inwards 
  • Lefsan
    solution d / infusion 
    M.Biotek Limited     United Kingdom
  • Luffie
    pills inwards 
  • MACLEVO®
    solution d / infusion 
  • MACLEVO®
    pills inwards 
  • OD-Levox
    pills inwards 
  • Oftakwix
    drops d / eye 
    Santen, AO     Finland
  • Remedy
    pills inwards 
  • Remedy
    solution d / infusion 
  • Rofloks-Scan
    pills inwards 
    Rowecq Limited     United Kingdom
  • Signtsef®
    drops d / eye 
  • Tavanic®
    pills inwards 
  • Tavanic®
    solution d / infusion 
  • Tanflomed
    pills inwards 
  • Flexible®
    pills
    Lek dd     Slovenia
  • Flexible®
    solution d / infusion 
    Sandoz d.     Slovenia
  • Floracid®
    pills inwards 
    VALENTA PHARM, PAO     Russia
  • Hayle Flox
    pills inwards 
  • Ecolevid®
    pills inwards 
    AVVA RUS, OJSC     Russia
  • Eleflox
    pills inwards 
  • Eleflox
    solution d / infusion 
  • Included in the list (Order of the Government of the Russian Federation No. 2782-r of 30.12.2014):

    VED

    ONLS

    АТХ:

    J.01.M.A   Fluoroquinolones

    J.01.M.A.12   Levofloxacin

    Pharmacodynamics:

    Levofloxacin is a left-handed isomer of ofloxacin. The broad-spectrum antibacterial drug inhibits the synthesis of DNA by blocking DNA gyre, disrupting the cross-linking of DNA gaps, destroys the cytoplasm, cell wall and bacterial membranes.

    Has a wide range of antibacterial activity against Gram-positive and Gram-negative bacteria, as well as anaerobic microflora and certain microorganisms: mycoplasma, rickettsia, ureaplasma.

    Pharmacokinetics:

    Bioavailability after oral administration is 99-100%. The maximum concentration of the drug in the blood plasma is reached after 1.3 hours. The connection with plasma proteins is 30-40%, penetrates into all tissues and organs, including leukocytes and alveolar macrophages.

    The half-life is 6-8 hours.

    It is metabolized and deactivated in the liver, eliminated by the kidneys - about 87% for 48 hours, less than 4% with feces for 72 hours. Up to 12% is removed during hemodialysis.

    Indications:

    It is used for the treatment of infectious and inflammatory diseases caused by sensitive microorganisms, both in acute and chronic stages of diseases.

    I.A30-A49.A41.9   Septicemia, unspecified

    X.J30-J39.J32.8   Other chronic sinusitis

    X.J30-J39.J32   Chronic Sinusitis

    X.J00-J06.J01   Acute Sinusitis

    X.J40-J47.J40   Bronchitis, not specified as acute or chronic

    X.J20-J22.J20   Acute bronchitis

    XII.L00-L08.L03   Phlegmon

    XI.K65-K67.K65.0   Acute peritonitis

    XI.K80-K87.K81.1   Chronic cholecystitis

    XI.K80-K87.K81.0   Acute cholecystitis

    XIV.N10-N16.N11.1   Chronic obstructive pyelonephritis

    X.J10-J18.J15   Bacterial pneumonia, not elsewhere classified

    Contraindications:

    Epilepsy, severe renal failure (creatinine clearance less than 20 ml / min), deficiency of glucose-6-phosphate dehydrogenase.

    Individual intolerance.

    Carefully:Older patients with kidney hypofunction probability.
    Pregnancy and lactation:

    Recommendations for FDA - Category C. It is used in pregnant women only for life indications. During treatment with the drug it is recommended to stop breastfeeding.

    Dosing and Administration:

    Inside or intravenously drip (within 1 hour) for 250-500 mg every 24 hours. The course of treatment is 7-10 days.

    The highest daily dose: 500 mg.

    The highest single dose: 500 mg.

    Side effects:

    Central and peripheral nervous system: dizziness, headache, drowsiness, paresthesia in the hands, hallucinatory disorders, seizures,decreased tactile sensitivity.

    The cardiovascular system: rarely - tachycardia.

    The system of hematopoiesis: neutropenia, thrombocytopenia, eosinophilia.

    Metabolism: rarely - hypoglycemia.

    Digestive system: dyspeptic disorders, diarrhea, increased activity of liver enzymes AST, ALT.

    Musculoskeletal: tendon lesions (children's age), muscle weakness, rarely - rhabdomyolysis.

    Dysbacteriosis.

    Allergic reactions.

    Overdose:

    Symptoms: disorders of consciousness, convulsive attacks by the type of epipriplets.

    Treatment: symptomatic.

    Interaction:

    With simultaneous use with theophylline, there is a decrease in convulsive activity.

    Glucocorticoids increase the risk of rupture of tendons.

    With the simultaneous use of vitamin K antagonists, hemorrhagic diathesis may develop.

    Special instructions:

    In the treatment of patients who have suffered a stroke or severe craniocerebral injury, convulsive activity increases.

    Treatment with levofloxacin can begin, without waiting for the result of bacteriological studies of the sensitivity of the pathogenic flora to antibiotics.

    Given the possible complications of the central nervous system, patients are undesirable to drive cars and perform work in an unstable position of the body.

    Instructions
    Up